CoapTech: Funding, Investors & Team (Oct 2026)
CoapTech is an early-stage medical device company aiming to improve medical care delivery for patients young and old around the world. The company seeks to bring a series of breakthrough medical devices to worldwide markets, leveraging a patent-pending, disruptive technology called Coaptive Ultrasound which is owned by the company. Its devices reduce health care costs and improve safety, quality, patient experience, and access to services around the globe. Invented by Dr. Tropello, the CoapTech delivers a novel platform technology combining magnetic attraction for device placement guidance, and low-cost, point-of-care ultrasound for visual feedback in diagnostic, interventional and therapeutic procedures. Strong rare-earth magnets are used to manually guide device placement inside the human body, while real-time, low cost ultrasound provides visual feedback to the clinician to ensure safety. This platform technology, invented by the company founder, has the potential to disrupt multiple medical procedures, substantially reducing costs while improving safety and patient experience. Their lead use case, selected because of its low risk, clear FDA pathway, and strong commercial viability, is for the insertion of gastrostomy tubes. They have defined the use of Coaptive Ultrasound to perform this novel gastrostomy procedure, as Percutaneous Ultrasound Gastrostomy (PUG). Briefly, PUG is a point-of-care (as opposed to operating room) procedure for inserting gastrostomy tubes which can be quickly and easily performed by non-surgical providers. It employs readily available medical devices such as ultrasound, feeding tubes, guide-wires, and dilators.
CoapTech has raised $15.0M across 4 funding rounds on record, the most recent an undisclosed round of $7.1M announced in Sep 2024.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CoapTech Company Profile and Key Stats
Latest funding round on record: Sep 2024.
CoapTech Funding Rounds
CoapTech raised $7.0M in an undisclosed round announced in Sep 2020.
1.3 years later, a Grant of $100k was announced in Jan 2022.
1.3 years later, an undisclosed round of $790k was announced in Apr 2023.
1.4 years later, an undisclosed round of $7.1M was announced in Sep 2024.
CoapTech Founders and Leadership Team
Contact details for the CoapTech team: 1 of 1 has an email address on file.
Start 14-day free trial →CoapTech Funding Compared to Other Biotechnology Startups
CoapTech's latest round of $7.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CoapTech in Biotechnology and Baltimore
Companies Similar to CoapTech
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
CoapTech Funding FAQs
What does CoapTech do?
CoapTech is an early-stage medical device company aiming to improve medical care delivery for patients young and old around the world. The company seeks to bring a series of breakthrough medical devices to worldwide markets, leveraging a patent-pending, disruptive technology called Coaptive Ultrasound which is owned by the company. Its devices reduce health care costs and improve safety, quality, patient experience, and access to services around the globe. Invented by Dr. Tropello, the CoapTech delivers a novel platform technology combining magnetic attraction for device placement guidance, and low-cost, point-of-care ultrasound for visual feedback in diagnostic, interventional and therapeutic procedures. Strong rare-earth magnets are used to manually guide device placement inside the human body, while real-time, low cost ultrasound provides visual feedback to the clinician to ensure safety. This platform technology, invented by the company founder, has the potential to disrupt multiple medical procedures, substantially reducing costs while improving safety and patient experience. Their lead use case, selected because of its low risk, clear FDA pathway, and strong commercial viability, is for the insertion of gastrostomy tubes. They have defined the use of Coaptive Ultrasound to perform this novel gastrostomy procedure, as Percutaneous Ultrasound Gastrostomy (PUG). Briefly, PUG is a point-of-care (as opposed to operating room) procedure for inserting gastrostomy tubes which can be quickly and easily performed by non-surgical providers. It employs readily available medical devices such as ultrasound, feeding tubes, guide-wires, and dilators.
How much funding has CoapTech raised?
CoapTech has raised $15.0M across 4 rounds on record. The most recent is an undisclosed round of $7.1M announced in Sep 2024.
When did CoapTech last raise funding?
CoapTech's most recent funding round on record is an undisclosed round of $7.1M, announced in Sep 2024.
Who is the CEO of CoapTech?
Howard Carolan is listed as CEO at CoapTech.
Where is CoapTech headquartered?
CoapTech is based in Baltimore, Maryland, United States.
How many employees does CoapTech have?
CoapTech is in the 11-50 employee band.
How does CoapTech's funding compare to other Biotechnology startups?
CoapTech's latest round of $7.1M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's CoapTech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CoapTech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.